Products & Information Collection of New variant SARS-COV-2 (2019nCOV) -Brazilian variants: P.1 lineage(B.1.1.28.1)
Diagnostic antibodies and antigens for Companion Animal disease testing
● Rabbit
Diagnostic antibodies and antigens for Swine disease testing
Diagnostic antibodies and antigens for Avian disease testing
Diagnostic antibodies and antigens for Multiple animal disease testing
Diagnostic antibodies and antigens for Ruminant disease testing
● Deer
Diagnostic antibodies and antigens for infectious and non-infectious Equine/Horse disease testing
SOCAIL MEDIA
The world is in midst of the COVID-19 pandemic.The SARS-CoV-2 lineage B.1.1.28 has been evolving in Brazil since February 2020. A new lineage, named P.1 (B.1.1.28.1), contains convergent mutations in the spike (S) protein, including several receptor binding domain (spike RBD) mutations E484K, K417T, and N501Y.
| Spike Mutation in SARS-COV-2 (2019nCOV) Brazilian variant P.1 lineage (B.1.1.28.1) |
Spike-S1 Subunit N Terminal |
L18F | |
| T20N | |||
| P26S | |||
| D138Y | |||
| R190S | |||
| Spike-S1-RBD | K417N | Important residues mutation | |
| E484K | |||
| N501Y | |||
| Spike-S1 Subunit C Terminal | D614G | A popular mutation in different new SARS-CoV-2 lineage | |
| H655Y | |||
| Spike-S2 Subunit | T1027I | ||
| V1176F |
GeneMedi pseudotype virus (pseudovirus) of SARS-COV-2 (2019nCOV) P.1 lineage (B.1.1.28.1, Brazilian variant)
Taking responsibility to help accelerate the COVID-19 vaccine and therapeutic antibody discovery and development, GeneMedi had developed the pseudotype virus (pseudovirus) of SARS-COV-2 (2019nCOV) P.1 lineage(B.1.1.28.1, Brazilian variant), which will meet the evaluation of the efficacy of COVID19 vaccines and therapeutic antibodies.
SARS-COV-2 (2019nCOV)-P.1 lineage(B.1.1.28.1, Brazilian variant) of Spike protein & ACE2 competition binding assay for efficacy evaluation of COVID-19 vaccines and therapeutic antibodiess
GeneMedi codon-optimized spike mammalian expression vector for SARS-COV-2 (2019nCOV) - P.1 lineage(B.1.1.28.1, Brazilian variant)
GeneMedi designed a mammalian expression codon-optimized spike mutation/deletion variant vector for COVID-19 SARS-COV-2 (2019nCOV) P.1 lineage(B.1.1.28.1, Brazilian variant)
